Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2010
12/23/2010WO2010145798A1 Nmp-enriched extract
12/23/2010WO2010145778A1 MODIFIED siNA
12/23/2010WO2010145681A1 A process for preparing trichloroammineplatinate salt and the products obtained therein
12/23/2010WO2010145668A1 Novel phenylimidazole derivative as pde10a enzyme inhibitor
12/23/2010WO2010145653A1 Buffered gum base for high ph release
12/23/2010WO2010145523A1 Compounds having activity of anti-hcv and uses thereof
12/23/2010WO2010145376A1 Tripeptide boronic acid or boronic ester, preparative method and use thereof
12/23/2010WO2010145208A1 Diazahomoadamantane derivatives and methods of use thereof
12/23/2010WO2010145207A1 Liquiritigenin derivatives, preparation methods and uses thereof
12/23/2010WO2010145206A1 Preparation methods of optical isomers of stepholidine or its derivatives and intermediates thereof
12/23/2010WO2010145205A1 Traditional chinese medicine composition for treating swine influenza, preparation method and use thereof
12/23/2010WO2010145203A1 1,2,4-oxadiazol derivatives, their pharmaceutical compositions and their use as sphingosine 1-phosphate 1 receptor agonists
12/23/2010WO2010145202A1 Thiazole or thiadizaloe derivatives for use as sphingosine 1-phosphate 1 (s1p1) receptor agonists
12/23/2010WO2010145201A1 Compounds
12/23/2010WO2010145197A1 Novel 6-arylamino pyridone sulfonamides and 6-arylamino pyrazinone sulfonamdies as mek inhibitors
12/23/2010WO2010145192A1 Mangiferin-berberine salt, manufacturing method and use thereof
12/23/2010WO2010145186A1 Peptide deformylase inhibitor containing 2,5-dihydropyrrole and synthesis method thereof
12/23/2010WO2010145066A1 Compositions of sulfodehydroabietic acid disodium salt for preventing or treating hyperacid gastroenteritis and peptic ulcers and preparation methods thereof
12/23/2010WO2010145010A1 Treatment of hot flushes, vasomotor symptoms, and night sweats with sex steroid precursors in combination with selective estrogen receptor modulators
12/23/2010WO2010144959A1 Analogues of anti-fibrotic agents
12/23/2010WO2010128528A3 Piperidine derivatives useful for treatment of diebetes
12/23/2010WO2010127264A3 HNF4α ANTAGONISTS AND METHODS OF USE
12/23/2010WO2010126626A3 Dual mechanism inhibitors for the treatment of disease
12/23/2010WO2010124231A3 Modulation of gene expression using oligomers that target gene regions downstream of 3' untranslated regions
12/23/2010WO2010122275A8 Pharmaceutical preparation
12/23/2010WO2010121268A3 Regulation of aging by modulation of mitochondrial function
12/23/2010WO2010119161A3 Antiepileptic, hypocholesterolemic and neuroprotective compound
12/23/2010WO2010116342A3 Non-steroidal compounds for androgen receptor modulation, processes for the preparation and uses thereof
12/23/2010WO2010107225A3 Pharmaceutical composition for preventing and treating arthritis, containing sulforaphane as an effective ingredient
12/23/2010WO2010104281A3 Composition for improving atopic skin diseases
12/23/2010WO2010103130A3 Thiazolopyrimidine modulators as immunosuppressive agents
12/23/2010WO2010100658A3 Stable olanzapine tablets and the process for its preparation
12/23/2010WO2010095158A8 Pharmaceutical composition containing microcolloidal silver and carboxymethyl beta glucan for disinfection of the nasal mucosae, and process for preparation thereof
12/23/2010WO2010095042A3 Pyridocarbazole type compounds and applications thereof
12/23/2010WO2010088450A3 Arylamide derivatives useful in the treatment of diseases associated with serca activity
12/23/2010WO2010084505A3 Stable topical formulation comprising voriconazole
12/23/2010WO2010084504A3 Oral solid dosage form containing rosiglitazone and a biguanide
12/23/2010WO2010082219A4 An arteether injection for treatment of malaria
12/23/2010WO2010080757A3 Combinations with an alpha-4beta-2 nicotinic agonist
12/23/2010WO2010079045A3 Crystalline salt forms of flibanserine
12/23/2010WO2010072770A3 Griseofulvin analogues for the treatment of cancer by inhibition of centrosomal clustering
12/23/2010WO2010063630A3 Pancreatic tumour treatment
12/23/2010WO2010054278A3 Compounds for the treatment of inflammatory disorders
12/23/2010WO2010041274A3 Process for the preparation of carbonate salts of cross-linked amine polymers
12/23/2010WO2010029576A3 Anti inflammatory compounds
12/23/2010WO2010010464A3 Fesoterodine comprising a reduced amount of dehydroxyfesoterodine
12/23/2010WO2009150535A8 Dronedarone for the prevention of permanent atrial fibrillation
12/23/2010WO2009146555A8 Hiv integrase inhibitors from pyridoxine
12/23/2010WO2009122252A3 Dental composition for treating peri-imlantitis
12/23/2010WO2009090558A3 Poloxamer foamable pharmaceutical compositions with active agents and/or therapeutic cells and uses
12/23/2010US20100325743 Marks as modifiers of the p53 pathway and methods of use
12/23/2010US20100324564 Particles, grains or granules for the treatment of an injured vertebra
12/23/2010US20100324322 Zinc-monocysteine complex and method of using zinc-cysteine complexes
12/23/2010US20100324277 Oligomeric compounds comprising 4'-thionucleosides for use in gene modulation
12/23/2010US20100324274 Novel synthetic ganglioside derivatives and compositions thereof
12/23/2010US20100324152 Use of 1,2-decanediol for sebum reduction and cosmetic and/or dermatological formulations comprising 1,2-decanediol
12/23/2010US20100324151 Methods and compositions for the treatment of infection or infectious colonization of the eyelid, ocular surface, skin or ear
12/23/2010US20100324150 Hyperbranched polyglycerol for improving heart function
12/23/2010US20100324149 Methods And Compositions For Prevention And Treatment Of Inflammatory Disease, Autoimmune Disease, and Transplant Rejection
12/23/2010US20100324148 Vitamin k for prevention and treatment of skin rash secondary to anti-egfr therapy
12/23/2010US20100324147 Arylcyclopropylamines and methods of use
12/23/2010US20100324146 Dendrimeric Enzyme Inhibitors
12/23/2010US20100324145 Crystalline ACAT Inhibitor
12/23/2010US20100324144 Therapy for hyperexcitability disorders
12/23/2010US20100324143 Bis(thio-hydrazide amide) salts for treatment of cancers
12/23/2010US20100324141 High purity 2-[4-(3- or 2-fluorobenzyloxy)benzylamino]propanamides and methods of use thereof
12/23/2010US20100324140 Glucagon receptor antagonists, preparation and therapeutic uses
12/23/2010US20100324139 Process to pregabalin
12/23/2010US20100324138 Lipoxin A4 Protection for Retinal Cells
12/23/2010US20100324137 Lauric arginate as a contact antimicrobial
12/23/2010US20100324135 Disinfectant and method of making
12/23/2010US20100324134 Medicament for preventive and/or therapeutic treatment of bowel disease
12/23/2010US20100324133 Branched Diepoxide Compounds for the Treatment of Inflammatory Disorders
12/23/2010US20100324132 Methods and compositions for promoting wound healing
12/23/2010US20100324131 Salvinorin Derivatives and Uses Thereof
12/23/2010US20100324130 Daa peripheral benzodiazepine receptor ligand for cancer imaging and treatment
12/23/2010US20100324128 9, 10-Alpha, Alpha-OH-Taxane Analogs and Methods for Production Thereof
12/23/2010US20100324127 Treating neurodegenerative diseases with progranulin
12/23/2010US20100324126 Syn3 compositions and methods
12/23/2010US20100324125 Proteins derived from white spot syndrome virus and uses thereof
12/23/2010US20100324123 Glms riboswitches, structure-based compound design with glms riboswitches, and methods and compositions for use of and with glms riboswitches
12/23/2010US20100324122 Modulation of sglt2 expression
12/23/2010US20100324121 Methods and compositions for the specific inhibition of gene expression by double-stranded rna
12/23/2010US20100324120 Lipid formulation
12/23/2010US20100324119 Reducing irf4, dusp22, or flj43663 polypeptide expression
12/23/2010US20100324118 Method for the Promotion of Angiogenesis, Vascularization, or Vascular Repair or for the Inhibition of Tumor Angiogenesis
12/23/2010US20100324117 Hepatitis c dsrna effector molecules, expression constructs, compositions, and methods of use
12/23/2010US20100324116 Fas/fasl or other death receptor targeted methods and compositions for killing tumor cells
12/23/2010US20100324115 Treatment of Squamous Cell Carcinoma with HSP27 Antisense Oligonucleotides and Radiotherapy
12/23/2010US20100324114 Methods and kits to detect hereditary angioedema type III
12/23/2010US20100324113 Delivery Method
12/23/2010US20100324112 Genetic changes in ATM and ATR/CHEK1 as prognostic indicators in cancer
12/23/2010US20100324111 Combination comprising pyrrolidone-5-carboxylic acid and at least one compound from citrulline, arginine and aspragine, and use thereof in the tratment of atopic dermatitis
12/23/2010US20100324110 Self Solidifying Bioerodible Barrier Implant
12/23/2010US20100324109 Composition for Topical Use
12/23/2010US20100324108 Substituted isoindoline-1,3-dione derivatives
12/23/2010US20100324107 USE OF PHTHALIMIDE AND/OR SULPHONAMIDE DERIVATIVES IN THE TREATMENT OF DISEASES WHICH REQUIRE REDUCING THE TNF-alpha LEVELS AND AN EXOGENOUS SOURCE OF NITRIC OXIDE, PHTHALIMIDE DERIVATIVES, SULPHONAMIDE DERIVATIVES, AND A METHOD FOR OBTAINING A SULPHONAMIDE DERIVATIVE
12/23/2010US20100324106 Compounds
12/23/2010US20100324105 Methods of Reducing Serum Glucose and Triglyceride Levels and for Inhibiting Angiogenesis Using Substituted Indolealkanoic Acids
12/23/2010US20100324104 1,2,3-triazoles as 11-beta hydroxysteroid dehydrogenase type i inhibitors
1 ... 1943 1944 1945 1946 1947 1948 1949 1950 1951 1952 1953 1954 1955 1956 1957 1958 1959 1960 1961 1962 1963 ... 7860